3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
30
Oropharyngeal Neoplasms
21
Nasopharyngeal Carcinoma
15
Head and Neck Neoplasms
13
Prostatic Neoplasms
11
Laryngeal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Squamous Cell
8
Carcinoma
8
Breast Neoplasms
8
Rectal Neoplasms
7
Mouth Neoplasms
7
Hypopharyngeal Neoplasms
7
Glioma
6
Glioblastoma
6
Uterine Cervical Neoplasms
5
Papillomavirus Infections
5
Esophageal Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Nasopharyngeal Neoplasms
4
Astrocytoma
4
Mesothelioma, Malignant
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Tumor Virus Infections
2
Tongue Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Radiotherapy, Intensity-Modulated
×
1 year
×
Clear all
No trials found.